A novel decellularized conjunctival stroma biomaterial for conjunctival reconstruction following pterygium surgery
DCS used in primary pterygium surgery has a safety profile comparable to AM. It promotes rapid postoperative conjunctival healing, achieves a relatively low pterygium recurrence rate, and yields outcomes similar to AM. DCS provides a novel biomaterial option for conjunctival reconstruction after pterygium excision and the treatment of other conjunctival injuries.
Authors
- Fei Luo (ORCID: https://orcid.org/0000-0001-6692-1660)
- Ying Jie (ORCID: https://orcid.org/0000-0003-4003-2579)
- Shang Li
- Xiaodan Hu (ORCID: https://orcid.org/0000-0002-0100-5300)
- Shijing Deng
Institutions
- Beijing Tongren Hospital (CN)
Publication Details
- Journal
- International Journal of Ophthalmology
- Published
- 2025-12-17
- DOI
- https://doi.org/10.18240/ijo.2026.01.06
- Citations
- 1
- Primary Topic
- Corneal Surgery and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.36